Premature aging of cardiovascular/platelet function in polycystic ovarian syndrome

American Journal of Medicine

Volumn 126, Issue 7, 2013, Pages 640.e1-640.e7

  Chan, Wai Ping A ^a   Ngo, Doan T ^a   Sverdlov, Aaron L ^a   Rajendran, Sharmalar ^a   Stafford, Irene ^a   Heresztyn, Tamila ^a   Chirkov, Yuliy Y ^a   Horowitz, John D ^a  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

Aging; Nitric oxide; Polycystic ovary syndrome; Women

Indexed keywords

C REACTIVE PROTEIN; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE;

ADULT; AGING; ARTICLE; CARDIOVASCULAR FUNCTION; CASE CONTROL STUDY; CELL COUNT; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL PROGENITOR CELL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

EID: 84879166381     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2012.12.015     Document Type: Article

References (33)

1. D.A. Ehrmann Polycystic ovary syndrome N Engl J Med 352 12 2005 1223 1236
2. J.X. Wang, M.J. Davies, and R.J. Norman Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment Hum Reprod 16 12 2001 2606 2609
3. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) Hum Reprod 19 1 2004 41 47
4. R.J. Norman, S. Masters, and W. Hague Hyperinsulinemia is common in family members of women with polycystic ovary syndrome Fertil Steril 66 6 1996 942 947
5. A. Dunaif, A.R. Hoffman, and R.E. Scully Clinical, biochemical, and ovarian morphologic features in women with acanthosis nigricans and masculinization Obstet Gynecol 66 4 1985 545 552
6. T. Apridonidze, P.A. Essah, M.J. Iuorno, and J.E. Nestler Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome J Clin Endocrinol Metab 90 4 2005 1929 1935
7. R.S. Legro, A.R. Kunselman, W.C. Dodson, and A. Dunaif Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women J Clin Endocrinol Metab 84 1 1999 165 169
8. R.J. Norman Obesity, polycystic ovary syndrome and anovulation - how are they interrelated? Curr Opin Obstet Gynecol 13 3 2001 323 327
9. F. Orio Jr., S. Palomba, and T. Cascella Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome J Clin Endocrinol Metab 89 9 2004 4588 4593
10. G. Paradisi, H.O. Steinberg, and A. Hempfling Polycystic ovary syndrome is associated with endothelial dysfunction Circulation 103 10 2001 1410 1415
11. I. Tarkun, B.C. Arslan, Z. Canturk, E. Turemen, T. Sahin, and C. Duman Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation J Clin Endocrinol Metab 89 11 2004 5592 5596
12. D. Dereli, G. Ozgen, F. Buyukkececi, E. Guney, and C. Yilmaz Platelet dysfunction in lean women with polycystic ovary syndrome and association with insulin sensitivity J Clin Endocrinol Metab 88 5 2003 2263 2268
13. S. Rajendran, S.R. Willoughby, and W.P. Chan Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects Atherosclerosis 204 2 2009 509 514
14. S.R. Willoughby, S. Stewart, A.S. Holmes, Y.Y. Chirkov, and J.D. Horowitz Platelet nitric oxide responsiveness: a novel prognostic marker in acute coronary syndromes Arterioscler Thromb Vasc Biol 25 12 2005 2661 2666
15. R.A. Wild, B. Grubb, A. Hartz, J.J. Van Nort, W. Bachman, and M. Bartholomew Clinical signs of androgen excess as risk factors for coronary artery disease Fertil Steril 54 2 1990 255 259
16. A.J. Krentz, D. von Muhlen, and E. Barrett-Connor Searching for polycystic ovary syndrome in postmenopausal women: evidence of a dose-effect association with prevalent cardiovascular disease Menopause 14 2 2007 284 292
17. G.D. Azevedo, J.M. Duarte, M.O. Souza, E.S.T.D. Costa, E.M. Soares, and T.M. Maranhao Menstrual cycle irregularity as a marker of cardiovascular risk factors at postmenopausal years [Portuguese] Arq Bras Endocrinol Metabol 50 5 2006 876 883
18. I. Goubareva, E. Gkaliagkousi, A. Shah, L. Queen, J. Ritter, and A. Ferro Age decreases nitric oxide synthesis and responsiveness in human platelets and increases formation of monocyte-platelet aggregates Cardiovasc Res 75 4 2007 793 802
19. D.S. Celermajer, K.E. Sorensen, D.J. Spiegelhalter, D. Georgakopoulos, J. Robinson, and J.E. Deanfield Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women J Am Coll Cardiol 24 2 1994 471 476
20. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome Fertil Steril 81 1 2004 19 25
21. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 7 1985 412 419
22. M.M. de Resende, L.Y. Huw, H.S. Qian, and K. Kauser Role of endothelial nitric oxide in bone marrow-derived progenitor cell mobilization Handb Exp Pharmacol 180 2007 37 44
23. L.J. Goldstein, K.A. Gallagher, and S.M. Bauer Endothelial progenitor cell release into circulation is triggered by hyperoxia-induced increases in bone marrow nitric oxide Stem Cells 24 10 2006 2309 2318
24. R.H. Boger, S.M. Bode-Boger, and A. Szuba Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia Circulation 98 18 1998 1842 1847
25. Y.Y. Chirkov, L.P. Chirkova, and J.D. Horowitz Suppressed anti-aggregating and cGMP-elevating effects of sodium nitroprusside in platelets from patients with stable angina pectoris Naunyn Schmiedebergs Arch Pharmacol 354 4 1996 520 525
26. I.B. Wilkinson, J.R. Cockcroft, and D.J. Webb Pulse wave analysis and arterial stiffness J Cardiovasc Pharmacol 32 Suppl 3 1998 S33 S37
27. T. Heresztyn, M.I. Worthley, and J.D. Horowitz Determination of l-arginine and NG, NG - and NG, NG' -dimethyl-L-arginine in plasma by liquid chromatography as AccQ-Fluor fluorescent derivatives J Chromatogr B Analyt Technol Biomed Life Sci 805 2 2004 325 329
28. M. Vasa, S. Fichtlscherer, and A. Aicher Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease Circ Res 89 1 2001 E1 E7
29. E. Diamanti-Kandarakis, K. Alexandraki, and C. Piperi Inflammatory and endothelial markers in women with polycystic ovary syndrome Eur J Clin Invest 36 10 2006 691 697
30. Y.Y. Chirkov, A.S. Holmes, L.P. Chirkova, and J.D. Horowitz Nitrate resistance in platelets from patients with stable angina pectoris Circulation 100 2 1999 129 134
31. S.R. Willoughby, S. Rajendran, and W.P. Chan Ramipril sensitizes platelets to nitric oxide: implications for therapy in high-risk patients J Am Coll Cardiol 60 10 2012 887 894
32. W.P. Castelli Epidemiology of coronary heart disease: the Framingham study Am J Med 76 2A 1984 4 12
33. D. Heutling, H. Schulz, and I. Nickel Asymmetrical dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment J Clin Endocrinol Metab 93 1 2008 82 90